Medullary Carcinoma of the Breast
1997; Wiley; Volume: 105; Issue: S75 Linguagem: Inglês
10.1111/j.1600-0463.1997.tb05606.x
ISSN1600-0463
Autores Tópico(s)HER2/EGFR in Cancer Research
ResumoAPMISVolume 105, Issue S75 p. 5-31 Medullary Carcinoma of the Breast LISE PEDERSEN, LISE PEDERSENSearch for more papers by this author LISE PEDERSEN, LISE PEDERSENSearch for more papers by this author First published: 11 October 2011 https://doi.org/10.1111/j.1600-0463.1997.tb05606.xCitations: 3AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat REFERENCES Andersen, K.W., Mouridsen, H.T., Castberg, T., Fischerman, K., Andersen, J., Hou-Jensen, K., Brincker, H., Johansen, H., Henriksen, E., Rørth, M., Rossing, N. Organisation of the Danish adjuvant trials in breast cancer. Dan. Med. Bull. 28: 102–106, 1981. CASPubMedWeb of Science®Google Scholar Andersen, K.W., Mouridsen, H.T. Danish Breast Cancer Cooperative Group (DBCG). Acta Oncol (Fasc 6a) 27: 627–647, 1988. 10.3109/02841868809091763 CASPubMedWeb of Science®Google Scholar Andersen, P.K., Væth, M. Statistisk analyse af overlevelsesdata ved lægevidenskabelige undersøgelser. FADL's Forlag, Copenhagen 1984. Google Scholar Armas, O.A., Gerald, W.L., Lesser, M.L., Arroyo, C.D., Norton, L., Rosen, P.P. Immunohistochemical detection of Cathepsin D in T2 N0 M0 breast carcinoma. Am. J. Surg. Pathol. 18: 158–166, 1994. 10.1097/00000478-199402000-00005 PubMedWeb of Science®Google Scholar Axelsson, C.K., Mouridsen, H.T., Zedeler, K. Axillary dissection of level I and II lymph nodes is important in breast cancer classification. Eur. J. Cancer 28 A: 1415–1418, 1992. 10.1016/0959-8049(92)90534-9 Web of Science®Google Scholar Bacus, S.S., Zelnick, C.R., Chin, D.M., Yarden, Y., Kaminsky, D.B., Bennington, J., Wen, D., Marcus, J.N., Page, D.L. Medullary carcinoma is associated with expression of intercellular Adhesion Molecule-1. Am. J. Pathol. 145: 1337–1348, 1994. CASPubMedWeb of Science®Google Scholar Balslev, I., Christensen, I.J., Rasmussen, B.R., Larsen, J.K., Lykkesfeldt, A.E., Thorpe, S.M., Rose, C., Briand, P., Mouridsen, H.T. Flow Cytometric DNA Ploidy Defines Patients With Poor Prognosis in Node-Negative Breast Cancer. Int. J. Cancer 56: 16–25, 1994. 10.1002/ijc.2910560105 CASPubMedWeb of Science®Google Scholar Ben-Ezra, J., Sheibani, K. Antigenic phenotype of the lympho-cytic component of medullary carcinoma of the breast. Cancer 59: 2037–2041, 1987. 10.1002/1097-0142(19870615)59:12 3.0.CO;2-G CASPubMedWeb of Science®Google Scholar Bergers, E., Diest, P.J.v., Baak, J.P.A. Cell Cycle Analysis of 932 Flow Cytometric DNA Histograms of Fresh Fresh Frozen Breast Carcinoma Material. Cancer 77: 2258–66, 1996. 10.1002/(SICI)1097-0142(19960601)77:11 3.0.CO;2-W CASPubMedWeb of Science®Google Scholar Bloom, H.J.G., Richardson, W.W. Histological grading and prognosis in breast cancer. A study of 1409 cases of which 359 have been followed for 15 years. Br. J. Cancer 11: 359–377, 1957. 10.1038/bjc.1957.43 CASPubMedWeb of Science®Google Scholar Bloom, H.J.G., Richardson, W.W., Field, J.R. Host resistance and survival in carcinoma of the breast: A study of 104 cases of medullary carcinoma in a series of 1,411 cases of breast cancer followed for 20 years. Br. Med. J. 3: 181–188, 1970. 10.1136/bmj.3.5716.181 CASPubMedWeb of Science®Google Scholar Bosari, S., Lee, A.K.C., DeLellis, R.A., Wiley, B.D., Heatly, G.J., Silverman, M.L. Microvessel quantitation and prognosis in invasive breast carcinoma. Hum. Pathol. 23: 755–761, 1992. 10.1016/0046-8177(92)90344-3 CASPubMedWeb of Science®Google Scholar Camplejohn, R.S., Ash, C.M., Gillet, C.E., Raikundalia, B., Barnes, D.M., Gregory, W.M., Richards, M.A., Millis, R.R. The prognostic significance of DNA flow cytometry in breast cancer: results from 881 patients treated in a single centre. Br. J. Cancer 71: 140–145. Google Scholar Carter, D., Pipkin, R.D., Shepard, R.H. Relationship of necrosis and tumor border to lymph node metastases and 10-year survival in carcinoma of the breast. Am. J. Surg. Pathol. 2: 39–46, 1978. 10.1097/00000478-197803000-00005 CASPubMedWeb of Science®Google Scholar Christensen, I., Hartmann, N.R., Keiding, N., Larsen, J.K., Noer, H., Vindeløv, L. Statistical analysis of DNA distribution from cell populations with partial synchrony. In: D. Lutz Ed) Pulse-Cytophotometry III. European Press, Ghent, 1978, pp 519–526. Google Scholar Cohen, J. A coefficient of agreement for nominal scales. Educat. Psychol. Measurement 20: 37–46, 1960. 10.1177/001316446002000104 PubMedWeb of Science®Google Scholar Cook, D.L., Weaver, D.L. Comparison of DNA Content, S-Phase Fraction, and Survival between Medullary and Ductal Carcinoma of the Breast. Am. J. Clin. Pathol. 104: 17–22, 1995. 10.1093/ajcp/104.1.17 CASPubMedWeb of Science®Google Scholar Cox, D.R. Regression models and life-tables. J. Roy. Statist. Soc. Sect. B34: 187–200, 1972. Google Scholar Cutler, S.J., Black, M.M., Friedell, G.H., Vidone, R.A., Goldenberg, I.S. Prognostic factors in cancer of the female breast. II. Reproducibility of histopathologic classification. Cancer 19: 75–82, 1966. 10.1002/1097-0142(196601)19:1 3.0.CO;2-4 CASPubMedWeb of Science®Google Scholar Delides, G.S., Garas, G., Georgouli, G., Jiortziotis, D., Lecca, J., Liva, T., Elemenoglou, J. Intralaboratory variations in the grading of breast carcinoma. Arch. Pathol. Lab. Med. 106: 126–128, 1982. CASPubMedWeb of Science®Google Scholar Domagala, W., Lasota, J., Dukowicz, A., Markiewski, M., Striker, G., Weber, K., Osborn, M. Vimentin expression appears to be associated with poor prognosis in node-negative ductal NOS breast carcinomas. Am. J. Pathol. 137: 1299–1304, 1990a. CASPubMedWeb of Science®Google Scholar Domagala, W., Wozniak, L., Lasota, J., Weber, K., Osborn, M. Vimentin is preferentially expressed in high-grade ductal and medullary, but not in lobular breast carcinomas. Am. J. Pathol. 137: 1059–1064, 1990b. CASPubMedWeb of Science®Google Scholar Domagala, W., Harezga, B., Szadowska, A., Markiewski, M., Weber, K., Osborn, M. Nuclear p53 protein accumulates preferentially in medullary and high-grade ductal but rarely in lobular breast carcinomas. Am. J. Pathol. 142: 669–674, 1993. CASPubMedWeb of Science®Google Scholar Domagala, W., Striker, G., Szadowska, A., Dukowicz, A., Harezga, B., Osborn, M. p53 protein and Vimentin in invasive ductal NOS breast carcinoma — Relationship with survival and sites of metastases. Eur. J. Cancer 30A: 1527–1534, 1994. 10.1016/0959-8049(94)00288-G CASPubMedWeb of Science®Google Scholar Dressler, L.G. Are DNA Flow Cytometry Measurements Providing Useful Information in the Management of the Node-Negative Breast Cancer Patient. Cancer Invest. 10(5): 477–486, 1992. 10.3109/07357909209024806 CASPubMedWeb of Science®Google Scholar Early Breast Cancer Trialists' Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. Lancet 339: 1–15, 1992a. 10.1016/0140-6736(92)90997-H PubMedGoogle Scholar Early Breast Cancer Trialists' Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. Lancet 339: 71–85, 1992b. 10.1016/0140-6736(92)90997-H PubMedWeb of Science®Google Scholar Ewers, S. Flow Cytometric DNA Analysis in Breast Cancer-Prospective evaluation of Prognosis and Prediction of Treatment Effects. Thesis. Lund, 1992. Grahns Bocktryckeri, Sweden, 1992. Google Scholar Ewertz, M. Breast Cancer in Denmark — Incidence, risk factors, and characteristics of survival. Thesis. University of Copenhagen. Copenhagen, 1993. Google Scholar Fernö, M., Baldetorp, B., Borg, Å., Olsson, H., Sigurdsson, H., Killander, D. Flow Cytometric DNA Index and S-Phase Fraction in Breast Cancer in Relation to Other Prognostic Variables and to clinical Outcome. Acta Oncol. 31: 157–165, 1992. 10.3109/02841869209088897 CASPubMedWeb of Science®Google Scholar Fisher, E.R., Gregorio, R.M., Fisher, B. The pathology of invasive breast cancer. Cancer 36: 1–84, 1975. 10.1002/1097-0142(197507)36:1 3.0.CO;2-4 CASPubMedWeb of Science®Google Scholar Fisher, E.R. Comment on "Interobserver reproducibility of histopathological features in Stage II breast cancer", by: K.W. Gilchrist et al.. Breast Cancer Res. Treat. 5: 11–13, 1985. 10.1007/BF01807643 CASPubMedWeb of Science®Google Scholar Fisher, E.R., Kenny, J.P., Sass, R., Dimitrov, N.V., Siderits, R.H., Fisher, B. Medullary cancer of the breast revisited. Breast Cancer Res. Treat. 16: 215–229, 1990a. 10.1007/BF01806330 CASPubMedWeb of Science®Google Scholar Fisher, E.R., Redmond, C., Fisher, B., Bass, G. Pathologic findings from the National Surgical Adjuvant Breast and Bowel projects (NSABP). Cancer 65: 2121–2128, 1990b. 10.1002/1097-0142(19900501)65:9+ 3.0.CO;2-M CASPubMedWeb of Science®Google Scholar Foote, F.W., Stewart, F.W. A histologic classification of carcinoma of the breast. Surgery 19: 74–99, 1946. PubMedWeb of Science®Google Scholar Frierson, H.F. Ploidy Analysis and S-Phase Fraction Determination by Flow Cytometry of Invasive Adenocarcinomaes of the Breast. Am. J. Surg. Pathol. 15(4): 358–367, 1991. 10.1097/00000478-199104000-00004 PubMedWeb of Science®Google Scholar Gaffey, M.J., Mills, S.E., Frierson, H.F., Zarbo, R.J., Boyd, J.C., Simpson, J.F., Weiss, L.M. Medullary carcinoma of the breast: Interobserver variability in histopathologic diagnosis. Modern Pathol. 8: 31–38, 1995. CASPubMedWeb of Science®Google Scholar Gaffey, M.J., Frierson, H.F., Mills, S.E., Boyd, J.C., Zarbo, R.J., Simpson, J.F., Gross, L.K., Weiss, L.M. Medullary carcinoma of the breast — Identification of lymphocyte sub-populations and their significance. Modern Pathol. 6: 721–728, 1993. CASPubMedWeb of Science®Google Scholar Gilchrist, K.W., Kalish, L., Gould, V.E., Hirschl, S., Imbriglia, J.E., Levy, W.M., Patchefsky, A.S., Penner, D.W., Pickren, J., Roth, J.A., Schinella, R.A., Schwartz, I.S., Wheeler, J.E. Interobserver reproducibility of histopathological features in stage II breast cancer. Breast Cancer Res. Treat. 5: 3–10, 1985. 10.1007/BF01807642 CASPubMedWeb of Science®Google Scholar Gjørup, T. Klinisk vurdering af diagnostiske undersøgelsesmetoder. Thesis. Lægeforeningens Forlag, Copenhagen, 1988. Google Scholar Gorski, C.M., Niepolomska, W., Nowak, K., Gebel, B., Plewa, T., Pysz, H., Adamus, J. Clinical evaluation and pathological grading in relation to other prognostic factors. In: Prognostic factors in breast cancer. Forrest & Kunkler Eds) pp 309–318, Williams and Wilkins, 1968. Google Scholar Hedley, D.W., Friedlander, M.L., Taylor, I.W., Rugg, C.A., Musgrove, E.A. Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. J. Histochem. Cytochem. 31: 1333–1335, 1983. 10.1177/31.11.6619538 CASPubMedWeb of Science®Google Scholar Hedley, D.W. DNA flow cytometry and breast cancer. Breast Cancer Res. Treat. 28: 51–53. Google Scholar Hedley, D.W., Clark, G.M., Cornelisse, C.J., Killander, D., Kute, T., Douglas, M. Consensus review of the clinical utility of DNA cytometry in carcinoma of the breast. Breast Cancer Res. Treat. 28: 55–59, 1993. 10.1007/BF00666357 CASPubMedWeb of Science®Google Scholar Helin, H.J., Helle, M.J., Kallioniemi, O.-P., Isola, J.J. Immunohistochemical determination of estrogen and progesterone receptors in human breast carcinoma — Correlation with histopathology and DNA flow cytometry. Cancer 63: 1761–1767, 1989. 10.1002/1097-0142(19900501)63:9 3.0.CO;2-3 CASPubMedWeb of Science®Google Scholar Holck, S., Pedersen, L., Schiødt, T., Zedeler, K., Mouridsen, H. Vimentin expression in 98 breast cancers with medullary features and its prognostic significance. Virchows Archiv A Pathol Anat 422: 475–479, 1993. 10.1007/BF01606456 CASPubMedWeb of Science®Google Scholar Hurlimann, J., Gebhard, S., Gomez, F. Oestrogen receptor, progesterone receptor, pS2, ERD5, HSP27 and cathepsin D in invasive ductal breast carcinomas. Histopathology 23: 239–248, 1993. 10.1111/j.1365-2559.1993.tb01196.x CASPubMedWeb of Science®Google Scholar Kandalaft, P.L., Chang, K.L., Ahn, C.W., Traweek, S.T., Mehta, P., Battifora, H. Prognostic significance of immunohisto-chemical analysis of Cathepsin D in low-stage breast cancer. Cancer 71: 2756–2763, 1993. 10.1002/1097-0142(19930501)71:9 3.0.CO;2-1 CASPubMedWeb of Science®Google Scholar Kurtz, J.M., Jacquemier, J., Torhorst, J., Spitalier, J.-M., Amalric, R., Hünig, R., Walther, E., Harder, F., Almendral, A., Brandone, H., Ayme, Y., Roth, J. Conservation therapy for breast cancers other than infiltrating ductal carcinoma. Cancer 63: 1630–1635, 1989. 10.1002/1097-0142(19890415)63:8 3.0.CO;2-U CASPubMedWeb of Science®Google Scholar Kute, T.E., Quadri, Y., Muss, H., Zbieranski, N., Cirrincione, C., Berry, D.A., Barcos, M., Thor, A.P., Liu. F., Koerner, F., Henderson, I.C. Flow Cytometry in Node-Positive Breast Cancer: Cancer and Leukemia Group B Protokol 8869. Cytometry 22: 297–306, 1995. 10.1002/cyto.990220406 CASPubMedWeb of Science®Google Scholar Landis, J.R., Koch, G.G. The measurement of observer agreement for categorical data. Biometrics 53: 159–174, 1977. 10.2307/2529310 Google Scholar Langley, F.A. Quality control in histopathology and diagnostic cytology. Histopathology 2: 3–18, 1978. 10.1111/j.1365-2559.1978.tb01689.x CASPubMedWeb of Science®Google Scholar Larsimont, D., Lespagnard, L., Degeyter, M., Heimann, R. Medullary carcinoma of the breast: a tumour lacking keratin 19. Histopathology 24: 549–552, 1994. 10.1111/j.1365-2559.1994.tb00574.x CASPubMedWeb of Science®Google Scholar Maier, W.P., Rosemond, G.P., Goldman, L.I., Kaplan, G.F., Tyson, R.R. A ten year study of medullary carcinoma of the breast. Surg. Gynecol. Obstet. 144: 695–698, 1977. CASPubMedWeb of Science®Google Scholar Mitze, M., Goepel, E. Prognostische Faktoren beim medullren Mammakarzinom. Geburtsh. u. Frauenheilk. 49: 635–641, 1989. 10.1055/s-2008-1026669 CASPubMedWeb of Science®Google Scholar Moore, O.S. Jr., Foote, F.W. The relatively favorable prognosis of medullary carcinoma of the breast. Cancer 2: 635–642, 1949. 10.1002/1097-0142(194907)2:4 3.0.CO;2-Q PubMedWeb of Science®Google Scholar Ottesen, G.L., Christensen, I.J., Larsen, J.K., Larsen, J., Christiansen, J., Baldetorp, B., Linden, T., Hansen, B., Andersen, J.A. DNA ploidy in breast cancer: A comparison of unfixed and fixed tissue, by image and flow cytometry. Anal Quant. Cytol. Histol. In press, March 1997. Google Scholar Pedersen, L., Holck, S., Schiødt, T. Medullary carcinoma of the breast. Cancer Treat. Rev. 15: 53–63, 1988. 10.1016/0305-7372(88)90009-6 CASPubMedWeb of Science®Google Scholar Pujol, P., Maudelonde, T., Daures, J.-P., Rouanet, P., Brouillet, J.-P., Pujol, H., Rochefort, H. A prospective study of the prognostic value of cathepsin D levels in breast cancer cytosol. Cancer 71: 2006–2012, 1993. 10.1002/1097-0142(19930315)71:6 3.0.CO;2-Q CASPubMedWeb of Science®Google Scholar Rank, F., Dombernowsky, P., Jespersen, N.C.B., Pedersen, B.V., Keiding, N. Histologic malignancy grading of invasive ductal breast carcinoma. — A regression analysis of prognostic factors in low-risk carcinomas from a multicenter trial. Cancer 60: 1299–1305, 1987. 10.1002/1097-0142(19870915)60:6 3.0.CO;2-L CASPubMedWeb of Science®Google Scholar Rapin, V., Contesso, G., Mouriesse, H., Bertin, F., Lacombe, M.J., Piekarski, J.D., Travagli, J.P., Gadenne, C., Friedman, S. Medullary breast carcinoma — A reevaluation of 95 cases of breast cancer with inflammatory stroma. Cancer 61: 2503–2510, 1988. 10.1002/1097-0142(19880615)61:12 3.0.CO;2-3 CASPubMedWeb of Science®Google Scholar Reiner, A., Reiner, G., Spona, J., Schemper, M., Holzner, J.H. Histopathologic characterization of human breast cancer in correlation with estrogen receptor status. Cancer 61: 1149–1154, 1988. 10.1002/1097-0142(19880315)61:6 3.0.CO;2-Z CASPubMedWeb of Science®Google Scholar Richardson, W.W. Medullary carcinoma of the breast. Br. J. Cancer 10: 415–426, 1956. 10.1038/bjc.1956.48 CASPubMedWeb of Science®Google Scholar Ridolfi, R.L., Rosen, P.P., Port, A., Kinne, D., Miké, V. Medullary carcinoma of the breast. Cancer 40: 1365–1385, 1977. 10.1002/1097-0142(197710)40:4 3.0.CO;2-N CASPubMedWeb of Science®Google Scholar Rigaud, C., Theobald, S., Noël, P., Badreddine, J., Barlier, C., Delobelle, A., Gentile, A., Jacquemier, J., Maisongrosse, V., de Latour, Peffault M., Trojani, M., Zafrani, B. Medullary carcinoma of the breast. Arch. Pathol. Lab. Med. 117: 1005–1008, 1993. CASPubMedWeb of Science®Google Scholar Rochefort, H. Cathepsin D in breast Cancer: A Tissue marker associated with metastasis. Eur. J. Cancer 28A: 1780–1783. Google Scholar Schiødt, T. Breast Carcinoma. Thesis. University of Copenhagen. Munksgaard, 1966. Google Scholar Schutte, B., Reynders, M.M.J., Bosman, F.T., Blijham, G.H. Flow cytometric determination of DNA ploidy level in nuclei isolated from paraffin-embedded tissue. Cytometry 6: 26–30, 1985. 10.1002/cyto.990060106 CASPubMedWeb of Science®Google Scholar Stenkvist, B., Westman-Naeser, S., Vegelius, J., Holmquist, J., Nordin, B., Bengtsson, E., Eriksson, O. Analysis of reproducibility of subjective grading systems for breast carcinoma. J. Clin. Pathol. 32: 979–985, 1979. 10.1136/jcp.32.10.979 CASPubMedWeb of Science®Google Scholar Shankey, T.V., Rabinovitch, P.S., Bagwell, B., Bauer, K.D., Cox, C., Duque, R.E., Hedley, D.W., Mayall, B.H., Wheeless, L. Guidelines for the implementation of clinical DNA cytometry. Breast Cancer Res. Treat. 28: 61–68, 1993. 10.1007/BF00666358 Web of Science®Google Scholar Svanholm, H., Starklint, H., Gundersen, H.J.G., Fabricius, J., Barlebo, H., Olsen, S. Reproducibility of histomorphologic diagnoses with special reference to the kappa statistic. APMIS 97: 689–698, 1989. 10.1111/j.1699-0463.1989.tb00464.x CASPubMedWeb of Science®Google Scholar Tanaka, H., Hori, M., Ohki, T. High endothelial venule and immunocompetent cells in typical medullary carcinoma of the breast. Virchows Archiv A Pathol. Anat. 420: 253–261, 1992. 10.1007/BF01600278 CASPubMedWeb of Science®Google Scholar Wargotz, E.S., Silverberg, S.G. Medullary carcinoma of the breast.: A Clinicopathologic study with appraisal of current diagnostic criteria. Hum. Pathol. 19: 1340–1346, 1988. 10.1016/S0046-8177(88)80290-9 CASPubMedWeb of Science®Google Scholar UICC Technical Report Series. An International Survey of Distributions of histologic types of breast cancer. P. Correa and William D. Johnson Eds.), vol. 35. UICC, Geneva 1978. Google Scholar Vindeløv, L.L., Christensen, I.J. A review of techniques and results obtained in one laboratory by an integrated system of methods designed for routine clinical flow cytometric DNA analysis. Cytometry 11: 753–770, 1990. 10.1002/cyto.990110702 PubMedWeb of Science®Google Scholar Visscher, D.W., Zarbo, R.J., Greenawald, K.A., Crissman, J.D. Prognostic Significance of Morphological Parameters and Flow Cytometric DNA Analysis in Carcinoma of the Breast. Pathol-Annu 25: 171–210, 1990. PubMedWeb of Science®Google Scholar Weidner, N., Folkman, J., Pozza, F., Bevilacqua, P., Allred, E.N., Moore, D.H., Meli, S., Gasparini, G. Tumor angiogenesis: A new significant and independent prognostic indicator in early-stage breast carcinoma. J. Natl. Cancer Inst. 84: 1875–1887, 1992. 10.1093/jnci/84.24.1875 CASPubMedWeb of Science®Google Scholar Weidner, N. Tumor angiogenesis: Review of current applications in tumor prognostication. Sem. Diagn. Pathol. 10: 302–313, 1993. CASPubMedWeb of Science®Google Scholar WHO. Histological Typing of Breast Tumours. Scarff & Torloni (eds). World Health Organization, Geneva, 1968. Google Scholar WHO. Histological Typing of Breast Tumours. 2nd ed., World Health Organization, Geneva, 1981. Google Scholar Zedeler, K. Assessment and presentation of survival experience in the Danish Breast Cancer Cooperative Group. Acta Oncol (Fasc. 6a) 27: 649–662, 1988. 10.3109/02841868809091764 CASPubMedWeb of Science®Google Scholar Citing Literature Volume105, IssueS75December 1997Pages 5-31 ReferencesRelatedInformation
Referência(s)